Accreditation, CME & MOC Information

The American College of Gastroenterology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Gastroenterology designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.5 AMA PRA Category 1 Credits™ for special evening webinars). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC point (1.5 Medical Knowledge MOC points for special evening webinars) in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Post-Activity CME & MOC Evaluation Information
Following the live webinar, all attendees from the webinar will be sent a link to the CME and MOC evaluation. ABIM MOC Points will be submitted to ABIM directly and will be visible on your ABIM account approximately 3-5 days later.

Please visit https://webinars.gi.org/home/index to submit your evaluation for a webinar that you attended or to print your CME certificate.

2023 Virtual Grand Rounds
Please complete your CME evaluation and MOC assessment soon after the activity. ABIM Board Certified physicians need to complete their MOC activities by December 31, 2023 in order for the MOC points to count toward any MOC requirements that are due by the end of the year. ACG will continue to submit participant completion data for the ACG 2023 Virtual Grand Rounds webinars until March 1, 2024, and any ABIM Board Certified physician who experienced a negative status change as a direct result of insufficient MOC points will have their status adjusted once the required number of points have been earned. No MOC credit may be awarded after March 1, 2024 for this activity.

2022 Virtual Grand Rounds
Please complete your CME evaluation and MOC assessment soon after the activity. ABIM Board Certified physicians need to complete their MOC activities by December 31, 2022 in order for the MOC points to count toward any MOC requirements that are due by the end of the year. ACG will continue to submit participant completion data for the ACG 2022 Virtual Grand Rounds webinars until March 1, 2023, and any ABIM Board Certified physician who experienced a negative status change as a direct result of insufficient MOC points will have their status adjusted once the required number of points have been earned. No MOC credit may be awarded after March 1, 2023 for this activity.

Disclosure Information

All of the relevant financial relationships listed for these individuals have been mitigated.

ACG Staff:

Mara Shapiro – Trellus Health, Inc.: Consultant; Sandoz: Speakers Bureau (terminated)

All other ACG staff involved in this activity have no financial relationship(s) with ineligible companies to disclose.

Faculty:

Individual faculty and moderator disclosures will be listed prior to the start of each lecture.

ACG VGR Planning Subcommittee:

Monjur Ahmed, MD, FACG, has no relevant financial relationship(s) to disclose with ineligible companies.

Mohammad Ismail, MD, has no relevant financial relationship(s) to disclose with ineligible companies.

Pichamol Jirapinyo, MD, MPH – Apollo Endosurgery: Advisory Board, Clinical Trial Participant, Consultant; Boston Scientific: Research Grant; Endosim: Patent Holder, Royalties; ERBE: Consultant; Fractyl: Clinical Trial Participant; GI Dynamics: Clinical Trial Participant, Consultant; Spatz Medical: Clinical Trial Participant; USGI Medical: Clinical Trial Participant

Abraham Khan, MD, FACG – Medtronic: Consultant; Progenity: Consultant

Harshit Khara, MD, FACG – Boston Scientific: Consultant; ConMed: Consultant; Medtronic: Consultant; Olympus: Consultant

Ian Lustbader, MD, FACG, has no relevant financial relationship(s) to disclose with ineligible companies.

Veeral Oza, MD – S4 medical: Advisory Board

Douglas Pleskow, MD, FACG – Allurion: Stockholder; Boston Scientific: Advisory Board, Consultant, Patent Holder; Fuji: Consultant; Olympus: Consultant

Kyle Staller, MD, MPH – Anji: Consultant; GI Supply: Consultant; Ironwood: Clinical Trial Participant; Sanofi: Consultant; Urovant: Clinical Trial Participant

Benjamin Tharian, MD, FACG – BSC: Consultant; Medtronic: Consultant; Olympus: Consultant

Guru Trikudanathan, MD – Boston Scientific Corporation: Consultant

Asad Ur Rahman, MD – AbbVie: Speakers Bureau

Peer Review:

ACG Educational Affairs Peer Review Subcommittee

None of the content reviewers for this educational activity have relevant financial relationship(s) with ineligible companies to disclose.

Steven L. Carpenter, MD, FACG
Daniel W. Bushyhead, MD
Raquel E. Davila, MD, FACG
Larry M. Deppe, MD
Adam S. Faye, MD
Frank K. Friedenberg, MD
Aaron S. Goldberg, MD, FACG
Dominique E. Howard, MD, FACG
Pujitha Kudaravalli, MD
Mitchell A. Mah’moud, MD, FACG
Mayssan Muftah, MD
Rishi D. Naik, MD
Judy W. Nee, MD
Pallavi Patil, MD
Seth J. Richter, MD, FACG
Kaveh Sharzehi, MD
Kenneth J. Vega, MD, FACG
Sonia S. Yoon, MD